"Hold on to your chairs if investors suddenly decide that a mutant strain has rendered ineffective the vaccines that drove the November rally. Magellan typically has half of its portfolio in cash and high-quality defensive equities, giving it defensive characteristics that should see it hold up relatively well in adverse markets."
I'd be surprised if all those chasing short term performance and switching from one fund to the next won't come back to a portfolio so well positioned for an 'escape mutant' as he so often mentions. Although this is good from a magellan perspective at the same time it is also saddening from a humanitarian perspective if we're back to square 1.
MFG Price at posting:
$32.00 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)